Back
Guardant Health 10K Form
Sell
22
GH
Guardant Health
Last Price:
35.00
Seasonality Move:
-1.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GH News And Ratings
See the #1 stock for the next 7 days that we like better than GH
GH Financial Statistics
Sales & Book Value
| Annual Sales: | $449.54M |
|---|---|
| Cash Flow: | $-100.53M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.49 |
| Price / Book: | 14.08 |
Profitability
| EPS (TTM): | -4.91000 |
|---|---|
| Net Income (TTM): | $-508.23M |
| Gross Margin: | $293.21M |
| Return on Equity: | -319.97% |
| Return on Assets: | -29.84% |
Guardant Health Earnings Forecast
Key Guardant Health Financial Ratios
- The Gross Profit Margin over the past 7 years for GH is 65.22%.
- The Selling, General & Administrative Expenses for GH have been equal to 103.17% of Gross Profit Margin.
- The Research & Development expenses have been 83.15% of Revenue.
- The Interest Expense is -0.39% of Operating Income.
- The Net Earning history of GH is -145.61% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 1 years.
Guardant Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Diagnostics & Research |
| Sector: | Healthcare |
| Current Symbol: | GH |
| CUSIP: | 40131M |
| Website: | guardanthealth.com |
Debt
| Debt-to-Equity Ratio: | 3.89 |
|---|---|
| Current Ratio: | 6.96 |
| Quick Ratio: | 6.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GH Technical Analysis vs Fundamental Analysis
Sell
22
Guardant Health (GH)
is a Sell
Is Guardant Health a Buy or a Sell?
-
Guardant Health stock is rated a Sell
The current Guardant Health [GH] share price is $35.01. The Score for GH is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.